EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A single dose recombinant AAV based CHIKV vaccine elicits robust and durable protective antibody responses in mice

Qin-Xuan Zhu, Ya-Nan Zhang, Hong-Qing Zhang, Chao Leng, Cheng-Lin Deng, Xin Wang, Jia-Jia Li, Xiang-Li Ye, Bo Zhang iD, Xiao-Dan Li iD

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0012604 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Qin-Xuan Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Technology and Translational Medicine, Hunan Normal University, Changsha, China. Hauptthemen laut MEDLINE: Dependovirus, Chikungunya virus, Chikungunya Fever, Antibodies, Viral. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key R&D Program of Hubei Jiangxia Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that is responsible for Chikungunya fever, which is characterized by fever, rash, and debilitating polyarthralgia. Since its re-emergence in 2004, CHIKV has continued to spread to new regions and become a severe health threat to global public. Development of safe and single dose vaccines that provide durable protection is desirable to control the spread of virus. The recombinant adeno-associated virus (rAAV) vectors represent promising vaccine platform to provide prolonged protection with a single-dose immunization. In this study, we developed a rAAV capsid serotype 1 vector based CHIKV vaccine and evaluated its protection effect against CHIKV challenge. Methodology The recombinant AAV1 encoding the full-length structural proteins of CHIKV (named as rAAV1-CHIKV-SP) was generated in vitro by transfecting the plasmids of AAV helper-free system into HEK-293T cells. The safety and immunogenicity of rAAV1-CHIKV-SP were tested in 4-week-old C57BL/6 mice. The antibody responses of the mice receiving prime-boost or single-dose immunization of the vaccine were determined by ELISA and plaque reduction neutralizing test. The immunized mice were challenged with CHIKV to evaluate the protection effect of the vaccine.

Conclusions

The rAAV1-CHIKV-SP showed remarkable safety and immunogenicity in C57BL/6 mice. A single dose intramuscular injection of rAAV1-CHIKV-SP elicited high level and long-lasting antibody responses, and conferred complete protection against a heterologous CHIKV strain challenge. These results suggest rAAV1-CHIKV-SP represents a promising vaccine candidate against different CHIKV clades with a simplified immunization strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusChikungunya virusChikungunya FeverAntibodies, ViralViral VaccinesMice, Inbred C57BLAntibodies, NeutralizingAnimalsMiceHumansHEK293 CellsFemaleGenetic VectorsVaccines, Synthetic

Substanzen

Antibodies, ViralViral VaccinesAntibodies, NeutralizingVaccines, Synthetic

Autor:innen und Institutionen

  • School of Medical Technology and Translational Medicine, Hunan Normal University, Changsha, China.
  • Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • University of Chinese Academy of Sciences, Beijing China.

ORCID-Profile: Bo Zhang, Xiao-Dan Li

Förderung

  • Key R&D Program of Hubei Jiangxia Laboratory

Zitieren

APA

Zhu, Q. X., Zhang, Y. N., Zhang, H. Q., Leng, C., Deng, C. L., Wang, X., Li, J. J., Ye, X. L., Zhang, B., & Li, X. D. (2024). A single dose recombinant AAV based CHIKV vaccine elicits robust and durable protective antibody responses in mice. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012604

Vancouver

Zhu QX, Zhang YN, Zhang HQ, Leng C, Deng CL, Wang X, et al. A single dose recombinant AAV based CHIKV vaccine elicits robust and durable protective antibody responses in mice. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012604

BibTeX
@article{Zhu2024,
  author = {Zhu, Qin-Xuan and Zhang, Ya-Nan and Zhang, Hong-Qing and Leng, Chao and Deng, Cheng-Lin and Wang, Xin and Li, Jia-Jia and Ye, Xiang-Li and Zhang, Bo and Li, Xiao-Dan},
  title = {A single dose recombinant AAV based CHIKV vaccine elicits robust and durable protective antibody responses in mice},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0012604}
}
Kostenlos starten →